# Incidental Renal Langerhans Cell Histiocytosis Within Clear Cell Renal Carcinoma: A Case Report and Literature Review

**Authors:** Charles-Antoine Garneau, Cathie Ouellet, Sophie Morin, Isabelle Harvey, Bruno Turcotte

PMC · DOI: 10.1155/criu/4441127 · Case Reports in Urology · 2025-11-10

## TL;DR

A 64-year-old man was found to have both kidney cancer and a rare immune cell disorder called LCH, which was discovered incidentally during cancer diagnosis.

## Contribution

This case report presents a rare coexistence of LCH and clear cell renal carcinoma in an adult with no prior history of either condition.

## Key findings

- LCH was incidentally found within the tissue of a clear cell renal carcinoma during pathological analysis.
- Immunohistochemical and genetic tests confirmed the presence of LCH markers and the BRAFV600E mutation.
- The patient had no prior history of LCH or urological issues, highlighting the rarity of this co-occurrence.

## Abstract

Langerhans cell histiocytosis (LCH) is a disease characterized by the excessive proliferation and abnormal differentiation of immune cells, including monocytes, T cells, and dendritic cells. The most affected organs are the bones, skin, lungs, liver, and spleen, while renal involvement is rare. LCH primarily affects children and is seldom diagnosed in adults. In this case report, we describe a 64-year-old man patient with no prior urological history nor history of LCH and presenting with both localized renal LCH and clear cell renal carcinoma (ccRCC). Renal cancer was first discovered fortuitously on an abdominal computed tomography (CT) scan while the patient presented symptoms of a complicated urinary tract infection. Following radical nephrectomy, LCH foci was detected as incidental histological finding within the ccRCC pathological analysis. Immunohistochemical staining confirmed the positivity of S-100 and CD1a markers and PCR analysis identified the BRAFV600E mutation. Based on these findings, a diagnosis of ccRCC associated with LCH was established.

## Linked entities

- **Proteins:** S100A1 (S100 calcium binding protein A1), CD1A (CD1a molecule)
- **Diseases:** Langerhans cell histiocytosis (MONDO:0017025), clear cell renal carcinoma (MONDO:0005005), urinary tract infection (MONDO:0005247)

## Full-text entities

- **Genes:** CD1A (CD1a molecule) [NCBI Gene 909] {aka CD1, FCB6, HTA1, R4, T6}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** Clear Cell Renal Carcinoma (MESH:D002292), LCH (MESH:D006646), urinary tract infection (MESH:D014552), Renal cancer (MESH:D007680)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** BRAFV600E

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12623108/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12623108/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12623108/full.md

---
Source: https://tomesphere.com/paper/PMC12623108